Front Range Biosciences Overview
- Year Founded
-
2015
- Status
-
Private
- Employees
-
45
- Latest Deal Type
-
Series B2
- Latest Deal Amount
-
$46M
- Investors
-
29
Front Range Biosciences General Information
Description
Operator of an agricultural biotech company intended to provide technology for the breeding and production of new plant varieties and seeds of valuable crops. The company offers rooted cuttings and pre-finished plants of hemp varieties, feminized hemp seeds, and nursery services, enabling cannabis cultivators to improve their yields, reduce disease, and create novel strains.
Contact Information
Website
www.frontrangebio.comCorporate Office
- 6400 Lookout Road
- Suite 200
- Boulder, CO 80301
- United States
Corporate Office
- 6400 Lookout Road
- Suite 200
- Boulder, CO 80301
- United States
Front Range Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Later Stage VC (Series B2) | 15-Jul-2021 | $46M | Completed | Generating Revenue | ||
| 9. Later Stage VC (Series B1) | Completed | Generating Revenue | ||||
| 8. Later Stage VC (Series A1) | 31-Dec-2020 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series B) | 14-Feb-2020 | Completed | Generating Revenue | |||
| 6. Angel (individual) | 31-Dec-2019 | Completed | Generating Revenue | |||
| 5. Angel (individual) | Completed | Generating Revenue | ||||
| 4. Early Stage VC (Series A) | 04-Oct-2018 | Completed | Generating Revenue | |||
| 3. Angel (individual) | 31-Dec-2017 | Completed | Generating Revenue | |||
| 2. Debt - General | 09-Aug-2016 | $30K | Completed | Generating Revenue | ||
| 1. Accelerator/Incubator | 25-Feb-2016 | $30K | $30K | Completed | Generating Revenue |
Front Range Biosciences Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B-2 | ||||||||
| Series B-1 | ||||||||
| Series B | ||||||||
| Series A-1 | 10,839,396 | $0.001000 | $2.22 | $2.22 | 1x | $1.96 | 12.52% | |
| Series A | 11,339,396 | $0.001000 | $2.22 | $2.22 | 1x | $1.96 | 13.09% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Front Range Biosciences Comparisons
Industry
Financing
Details
Front Range Biosciences Competitors (7)
One of Front Range Biosciences’s 7 competitors is Redag Crop, a Venture Capital-Backed company based in Manchester, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Redag Crop | Venture Capital-Backed | Manchester, United Kingdom | ||||
| Trait Biosciences | Venture Capital-Backed | Santa Fe, NM | ||||
| Klonetics | Venture Capital-Backed | Kelowna, Canada | ||||
| Enko | Venture Capital-Backed | Mystic, CT | ||||
| Segra | Venture Capital-Backed | Richmond, Canada |
Front Range Biosciences Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Front Range Biosciences Patents
Front Range Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20230357868-A1 | Compositions and methods for obtaining plant cultivars with desired terpene profiles based on terpene synthase gene selection | Pending | 29-Dec-2021 | ||
| US-20220256799-A1 | Cannabis plant named 'lpa004' | Pending | 17-Feb-2021 | ||
| US-20230002779-A1 | Characterization of plant cultivars based on terpene synthase gene profiles | Inactive | 29-Jun-2020 | ||
| CA-3188481-A1 | Characterization of cannabis cultivars based on terpene synthase gene profiles | Pending | 29-Jun-2020 | ||
| US-20240279670-A1 | Characterization of plant cultivars based on terpene synthase gene profiles | Pending | 29-Jun-2020 | C12N15/8245 |
Front Range Biosciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Front Range Biosciences Investors (29)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Advance Ventures | Venture Capital | Minority | ||
| Key Investment Partners | Venture Capital | Minority | ||
| Tuatara Capital | Growth/Expansion | Minority | ||
| AFI Capital Partners | Growth/Expansion | Minority | ||
| Alicia Syrett | Angel (individual) | Minority |
Front Range Biosciences Acquisitions (1)
Front Range Biosciences’s most recent deal was a Merger/Acquisition with Steep Hill (Genomics Research & Development Team). The deal was made on 15-Aug-2019.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Steep Hill (Genomics Research & Development Team) | 15-Aug-2019 | Merger/Acquisition | Other Pharmaceuticals and Biotechnology |
Front Range Biosciences FAQs
-
When was Front Range Biosciences founded?
Front Range Biosciences was founded in 2015.
-
Where is Front Range Biosciences headquartered?
Front Range Biosciences is headquartered in Boulder, CO.
-
What is the size of Front Range Biosciences?
Front Range Biosciences has 45 total employees.
-
What industry is Front Range Biosciences in?
Front Range Biosciences’s primary industry is Other Consumer Non-Durables.
-
Is Front Range Biosciences a private or public company?
Front Range Biosciences is a Private company.
-
What is the current valuation of Front Range Biosciences?
The current valuation of Front Range Biosciences is .
-
What is Front Range Biosciences’s current revenue?
The current revenue for Front Range Biosciences is .
-
How much funding has Front Range Biosciences raised over time?
Front Range Biosciences has raised $133M.
-
Who are Front Range Biosciences’s investors?
Advance Ventures, Key Investment Partners, Tuatara Capital, AFI Capital Partners, and Alicia Syrett are 5 of 29 investors who have invested in Front Range Biosciences.
-
Who are Front Range Biosciences’s competitors?
Redag Crop, Trait Biosciences, Klonetics, Enko, and Segra are some of the 7 competitors of Front Range Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
